This trial studies how well HIIT before surgery works in improving outcomes in patients with endometrial cancer. HIIT is an exercise strategy where short intense exercise periods are interspersed with recovery periods. Endometrial cancer is an obesity driven disease. Obesity creates a tumor enhancing environment. HIIT before surgery may improve outcomes in patients with endometrial cancer by slowing development of the tumor.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04025229.
PRIMARY OBJECTIVE:
I. Determine the anti-proliferative effect of high intensity interval training (HIIT) on the endometrium of women with endometrial cancer (EC) by comparing endometrial biopsy samples of patients before undergoing a HIIT intervention to their post-HIIT endometrial tissue/hysterectomy specimens.
EXPLORATORY OBJECTIVES:
I. To test if HIIT inhibits downstream targets of the insulin/IGF-1/AMPK/mTOR signaling pathway in the ECs.
II. Evaluate the preoperative impact of HIIT on cardiovascular and metabolic health in patients with EC, compared to standard of care.
IIa. To assess improvement in cardiorespiratory fitness with the HIIT intervention in EC patients.
IIb. To correlate improvement in obesity and insulin resistance with response to HIIT treatment in EC patients.
IIc. To test if the metabolic profiles of blood and tumor correspond to HIIT responsiveness in EC patients.
OUTLINE:
Patients complete HIIT exercises at home for 4-8 sessions, with at least 24 hours between sessions, before undergoing standard of care surgery.
After completion of study, patients are followed up at 2-4 weeks.
Lead OrganizationUNC Lineberger Comprehensive Cancer Center
Principal InvestigatorVictoria Lin Bae-Jump